Barometer Capital Management Inc. Ascendis Pharma A/S Transaction History
Barometer Capital Management Inc.
- $347 Billion
- Q3 2024
A detailed history of Barometer Capital Management Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Barometer Capital Management Inc. holds 1,004 shares of ASND stock, worth $131,584. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,004
Previous 1,004
-0.0%
Holding current value
$131,584
Previous $137 Million
9.48%
% of portfolio
0.04%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding ASND
# of Institutions
243Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.27 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$673 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$654 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$578 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$549 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.31B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...